In vitro application of the oncometabolite α-hydroxyglutarate (α-HG), typical of IDH-mutated gliomas, confirmed its direct effect on reduced expression of the chemokines CXCL9 and CXCL10 and thus on reduced migration of CD8+ T cells [18]. The gene discussed is CXCL9; the disease is central nervous system cancer.